| Miss Aliya Grace Jae Richards, CF-SLP | |
|
1710 Highway 121 Byp N Ste K, Murray, KY 42071-8762 | |
| (270) 767-6853 | |
| Not Available |
| Full Name | Miss Aliya Grace Jae Richards |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1710 Highway 121 Byp N Ste K, Murray, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639855919 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 285758 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Aliya Grace Jae Richards, CF-SLP 327 State Route 1686, Fancy Farm, KY 42039-9558 Ph: (270) 293-1914 | Miss Aliya Grace Jae Richards, CF-SLP 1710 Highway 121 Byp N Ste K, Murray, KY 42071-8762 Ph: (270) 767-6853 |
News Archive
Age has a significant impact on the variance of salivary markers of oxidative stress, and could shed light on the pathogenesis of oral diseases, report Slovakian researchers.
AstraZeneca and Targacept, Inc. today announced top-line results from the second of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.
Researchers have created a new, open-access tool that allows doctors and scientists to evaluate infant brain health by assessing the concentration of various chemical markers, called metabolites, in the brain. The tool compiled data from 140 infants to determine normal ranges for these metabolites.
GTx, Inc. announced the presentation of preclinical studies evaluating GTx-758, a selective estrogen receptor alpha agonist being developed for first line treatment of advanced prostate cancer, and GTx-230, a novel microtubule polymerization inhibitor.
Capstone Therapeutics announced today twelve-month results from its two AZX100 Phase 2a pilot clinical trials in keloid scarring and seven-month interim results of its ongoing AZX100 Phase 2a pilot clinical trial in surgical (trocar site) scarring.
› Verified 3 days ago
Mrs. Susan Michelle Osborne, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3120 Midway Rd, Murray, KY 42071 Phone: 270-492-8519 Fax: 270-492-8519 | |
Madison Taylor Cohoon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1710 Highway 121 Byp N Ste K, Murray, KY 42071 Phone: 270-767-6397 Fax: 270-767-6853 | |
Kyle Marshall, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Crossfield Dr, Murray, KY 42071 Phone: 270-753-9131 | |
Miss Hannah Grace Travis, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1710 Ky 121, Suite K, Murray, KY 42071 Phone: 270-767-6397 | |
Mrs. Cheryl S Crouch, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 803 Poplar St, Murray, KY 42071 Phone: 270-762-1557 | |
Megan Murphy Smetana, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2115 Edinborough Dr, Murray, KY 42071 Phone: 270-753-3120 | |
Hayes Cranor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1710 Highway 121 Byp N Ste K, Murray, KY 42071 Phone: 270-767-6397 |